Close

Analyst Ratings for Jazz Pharmaceuticals (JAZZ) [Buys]

JAZZ Rating Summary

JAZZ Price Target Summary

* Over Last 12-Mos
  |   Expand Research on JAZZ
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $184.58 (+53.3%) * Over Last 12-Mos
Rating Score: 8.4 / 10   Percentile Rank: 87%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/3/2024 Baird Joel Beatty New Coverage Outperform
(N/A)
160.00
(N/A)
123.00
(120.42)
-2.1% Details
12/8/2022 Goldman Sachs
» Updated 3/3/2023
Madhu Kumar Upgrade Buy
(Neutral)
212.00
(190.00)
151.10
(120.42)
-20.3% Details
Like JAZZ Ratings? Also take a look at MRK, LGND, TVTX, ZYME

JAZZ Ratings News